The global athlete’s foot drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The athlete's foot also known as tinea pedis is a fungal skin infection. It usually begins between the toes and occurs in people whose feet have become very sweaty while confined within tight-fitting shoes. The athlete's foot drug is used to treat fungal infection of the feet that causes the scaling and blistering of the soles, fissures at toes as well as painful and burning sensations along itching rashes. The major factor for the growth of the market is the increasing prevalence and rise in incidence rates of athlete’s foot globally. 

According to the National Center for Biotechnology Information (NCBI), an athlete's foot is very common with an affection rate of an estimated 3 to 15% of the population. Additionally, as per the same source, men and older people are more likely to get it. Hence, the increasing prevalence of this infection is driving the growth of the global athlete’s foot drugs market during the forecast period. Furthermore, the market is propelling owing to the easy availability of over-the-counter (OTC) treatment coupled with the low cost of treatment. 

Some major players in the global athlete’s foot drugs market include Mylan N.V., Novartis International AG, and Pfizer Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in April 2021, Pfizer Inc. acquired Amplyx Pharmaceuticals. The acquisition was aimed to develop a new treatment for drug-resistant "superbug" for antifungal treatment.

Market Coverage

    • The market number available for – 2020-2027

    • Base year- 2020

    • Forecast period- 2021-2027

    • Segment Covered- 

o By Type

o By Treatment

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

    • Competitive Landscape-  Mylan N.V., Novartis International AG, and Pfizer Inc., among others.

Key questions addressed by the report

    • What is the market growth rate?

    • Which segment and region dominate the market in the base year?

    • Which segment and region will project the fastest growth in the market?

    • How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

    • Who is the leader in the market?

    • How players are addressing challenges to sustain growth?

    • Where is the investment opportunity?

Global Athlete’s Foot Drugs  Market Report by Segment

By Type 

    • Interdigital

    • Mocassin

    • Vesicular

By Treatment

    • Topical

    • Oral Antifungal Medication

    • Topical Oral Steroid

    • Oral Antibiotics

Global Athlete’s Foot Drugs Market Report by Region

North America

    • United States

    • Canada

Europe

    • UK

    • Germany

    • Italy

    • Spain

    • France

    • Rest of Europe 

Asia-Pacific

    • China

    • India

    • Japan

    • South Korea

    • Rest of Asia-Pacific 

Rest of the World

    • Latin America 

    • Middle East & Africa